Lauren Emily Scott, MD PhD

Assistant Professor, Family Medicine

Lauren Scott
617.414.4465
771 Albany Street

Biography

Lauren E Scott, MD, PhD is an Assistant Professor of Family Medicine at the Chobanian and Avedisian School of Medicine and physician at BMC Family Medicine at Melnea Cass.

Dr. Scott earned her Doctor of Medicine at Chobanian and Avedisian School of Medicine. She is board certified by the American Board of Family Medicine, as well as by the College of Family Physicians of Canada.

Her interests include health equity, integrating care of the whole family from newborns to elders, and is a registered civil surgeon, performing USCIS immigration physicals.

Education

  • Boston University School of Medicine, MD
  • University of British Columbia, PhD
  • McMaster University, BSc

Classes Taught

Publications

  • Published on 2/1/2014

    Telpoukhovskaia MA, Rodríguez-Rodríguez C, Cawthray JF, Scott LE, Page BD, Alí-Torres J, Sodupe M, Bailey GA, Patrick BO, Orvig C. 3-Hydroxy-4-pyridinone derivatives as metal ion and amyloid binding agents. Metallomics. 2014 Feb; 6(2):249-62. PMID: 23999879.

    Read at: PubMed
  • Published on 12/22/2013

    Telpoukhovskaia MA, Rodríguez-Rodríguez C, Scott LE, Page BD, Patrick BO, Orvig C. Synthesis, characterization, and cytotoxicity studies of Cu(II), Zn(II), and Fe(III) complexes of N-derivatized 3-hydroxy-4-pyridiones. J Inorg Biochem. 2014 Mar; 132:59-66. PMID: 24393377.

    Read at: PubMed
  • Published on 1/1/2011

    Scott LE, Telpoukhovskaia M, Rodríguez-Rodríguez C, Merkel M, Bowen ML, Page BDG, Green DE, Storr T, Thomas F, Allen DD, Lockman PR, Patrick BO, Adam MJ, Orvig C. N-Aryl-substituted 3-(ß-D-glucopyranosyloxy)-2-methyl-4(1H)-pyridinones as agents for Alzheimer's therapy. Chemical Science. 2011; 2:642-8.

  • Published on 12/11/2009

    Green DE, Bowen ML, Scott LE, Storr T, Merkel M, Böhmerle K, Thompson KH, Patrick BO, Schugar HJ, Orvig C. In vitro studies of 3-hydroxy-4-pyridinones and their glycosylated derivatives as potential agents for Alzheimer's disease. Dalton Trans. 2010 Feb 14; 39(6):1604-15. PMID: 20104324.

    Read at: PubMed
  • Published on 10/1/2009

    Scott LE, Orvig C. Medicinal inorganic chemistry approaches to passivation and removal of aberrant metal ions in disease. Chem Rev. 2009 Oct; 109(10):4885-910. PMID: 19637926.

    Read at: PubMed
  • Published on 3/5/2009

    Storr T, Scott LE, Bowen ML, Green DE, Thompson KH, Schugar HJ, Orvig C. Glycosylated tetrahydrosalens as multifunctional molecules for Alzheimer's therapy. Dalton Trans. 2009 Apr 28; (16):3034-43. PMID: 19352532.

    Read at: PubMed
  • Published on 10/6/2008

    Scott LE, Page BD, Patrick BO, Orvig C. Altering pyridinone N-substituents to optimise activity as potential prodrugs for Alzheimer's disease. Dalton Trans. 2008 Dec 07; (45):6364-7. PMID: 19002321.

    Read at: PubMed
  • Published on 5/19/2007

    Storr T, Merkel M, Song-Zhao GX, Scott LE, Green DE, Bowen ML, Thompson KH, Patrick BO, Schugar HJ, Orvig C. Synthesis, characterization, and metal coordinating ability of multifunctional carbohydrate-containing compounds for Alzheimer's therapy. J Am Chem Soc. 2007 Jun 13; 129(23):7453-63. PMID: 17511455.

    Read at: PubMed
  • Published on 1/1/2007

    Schugar H, Green DE, Bowen ML, Scott LE, Storr T, Böhmerle K, Thomas F, Allen DD, Lockman PR, Merkel M, Thompson KH, Orvig C. Combating Alzheimer's disease with multifunctional molecules designed for metal passivation. Angew Chem Int Ed Engl. 2007; 46(10):1716-8. PMID: 17397084.

    Read at: PubMed

View all profiles